Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Edgar Lomax Co. VA

Edgar Lomax Co. VA lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 2.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,218,155 shares of the pharmacy operator's stock after selling 28,925 shares during the period. Edgar Lomax Co. VA owned 0.14% of Walgreens Boots Alliance worth $11,365,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after acquiring an additional 2,279,495 shares during the last quarter. Invesco Ltd. raised its position in Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after purchasing an additional 2,631,332 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after purchasing an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. Finally, Norges Bank purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at $58,241,000. 58.59% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on WBA. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Bank of America raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price target for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has an average rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Stock Up 0.1 %

WBA traded up $0.02 on Thursday, hitting $11.01. The company had a trading volume of 3,730,400 shares, compared to its average volume of 23,175,100. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The stock has a market capitalization of $9.52 billion, a price-to-earnings ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a fifty day moving average price of $10.93 and a 200-day moving average price of $10.18.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.20 earnings per share. Analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.